Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Interferon-gamma (IFN-gamma) is an important mediator of immunity and inflammation that utilizes the JAK-STAT signaling pathway to activate the STAT1 transcription factor. Many functions of IFN-gamma have been ascribed to direct STAT1-mediated induction of immune effector genes, but recently it has become clear that key IFN-gamma functions are mediated by cross-regulation of cellular responses to other cytokines and inflammatory factors. Here, we review mechanisms by which IFN-gamma and STAT1 regulate signaling by Toll-like receptors, inflammatory factors, tissue-destructive cytokines, anti-inflammatory cytokines, and cytokines that activate opposing STATs. These signaling mechanisms reveal insights about how IFN-gamma regulates macrophage activation, inflammation, tissue remodeling, and helper and regulatory T cell differentiation and how Th1 and Th17 cell responses are integrated in autoimmune diseases.

[1]  B. Segal,et al.  IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition , 2008, The Journal of experimental medicine.

[2]  C. Elson,et al.  Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.

[3]  Frank O. Nestle,et al.  Mechanisms of Disease: Psoriasis. , 2009 .

[4]  D. Kono,et al.  Interferons as pathogenic effectors in autoimmunity , 2005, Immunological reviews.

[5]  Chilakamarti V. Ramana,et al.  Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Stauber,et al.  A phosphorylation-acetylation switch regulates STAT1 signaling. , 2009, Genes & development.

[7]  T. Taniguchi,et al.  Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. , 2003, Genes & development.

[8]  L. Wahl,et al.  Interferon-γ Differentially Regulates Monocyte Matrix Metalloproteinase-1 and -9 through Tumor Necrosis Factor-α and Caspase 8* , 2003, Journal of Biological Chemistry.

[9]  C. Dinarello,et al.  Cutting Edge: Negative Regulation of Dendritic Cells through Acetylation of the Nonhistone Protein STAT-31 , 2009, The Journal of Immunology.

[10]  L. Ivashkiv,et al.  Lipopolysaccharide-Induced Expression of Matrix Metalloproteinases in Human Monocytes Is Suppressed by IFN-γ via Superinduction of ATF-3 and Suppression of AP-11 , 2008, The Journal of Immunology.

[11]  G. Stark.  How cells respond to interferons revisited: from early history to current complexity. , 2007, Cytokine & growth factor reviews.

[12]  Ningli Li,et al.  Role of IFN-γ in induction of Foxp3 and conversion of CD4+ CD25– T cells to CD4+ Tregs , 2006 .

[13]  Richard M. Ransohoff,et al.  Stat1-independent regulation of gene expression in response to IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Benveniste,et al.  Interferon‐γ‐activated STAT‐1α suppresses MMP‐9 gene transcription by sequestration of the coactivators CBP/p300 , 2005 .

[15]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[16]  J. Carulli,et al.  Inflammatory arthritis can be reined in by CpG-induced DC–NK cell cross talk , 2007, The Journal of experimental medicine.

[17]  G. Lesinski,et al.  IFN-α-Induced Signal Transduction, Gene Expression, and Antitumor Activity of Immune Effector Cells Are Negatively Regulated by Suppressor of Cytokine Signaling Proteins1 , 2007, The Journal of Immunology.

[18]  J. Woodgett,et al.  IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. , 2006, Immunity.

[19]  J. Browning,et al.  Interferon blocks interleukin 1-induced prostaglandin release from human peripheral monocytes. , 1987, Journal of immunology.

[20]  Akira Yamaguchi,et al.  Regulation of osteoclast differentiation and function by the CaMK-CREB pathway , 2006, Nature Medicine.

[21]  C. de Wolf‐Peeters,et al.  Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. , 1999, Journal of immunology.

[22]  L. Steinman,et al.  Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). , 1996, Journal of immunology.

[23]  G. Roodman,et al.  Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. , 1986, Journal of immunology.

[24]  Xiaoyu Hu,et al.  Sensitization of IFN-γ Jak-STAT signaling during macrophage activation , 2002, Nature Immunology.

[25]  D. Radzioch,et al.  c-fos mRNA expression in macrophages is downregulated by interferon-gamma at the posttranscriptional level. , 1991, Molecular and cellular biology.

[26]  David E Levy,et al.  Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Ivashkiv,et al.  Crosstalk among Jak‐STAT, Toll‐like receptor, and ITAM‐dependent pathways in macrophage activation , 2007, Journal of leukocyte biology.

[28]  Y. Iwakura,et al.  Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category , 2008, The Journal of experimental medicine.

[29]  Y. E. Chin,et al.  Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue , 2005, Science.

[30]  L. Espinosa,et al.  Phosphorylation by Glycogen Synthase Kinase-3β Down-regulates Notch Activity, a Link for Notch and Wnt Pathways* , 2003, Journal of Biological Chemistry.

[31]  Paul J Hertzog,et al.  Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity , 2006, Nature Immunology.

[32]  W. Cowden,et al.  IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. , 1999, Journal of immunology.

[33]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[34]  Jianyuan Luo,et al.  Activation of Stat3 Sequence-specific DNA Binding and Transcription by p300/CREB-binding Protein-mediated Acetylation* , 2005, Journal of Biological Chemistry.

[35]  F. Nicoletti,et al.  Biphasic effect of interferon‐γ in murine collagen‐induced arthritis , 1995, European journal of immunology.

[36]  C. Horvath,et al.  Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Yee‐Shin Lin,et al.  Glycogen Synthase Kinase-3β Facilitates IFN-γ-Induced STAT1 Activation by Regulating Src Homology-2 Domain-Containing Phosphatase 21 , 2009, The Journal of Immunology.

[38]  C. Deng,et al.  Recent progress in the biology and physiology of sirtuins , 2009, Nature.

[39]  S. Ebong,et al.  Cell Proliferation and STAT6 Pathways Are Negatively Regulated in T Cells by STAT1 and Suppressors of Cytokine Signaling , 2004, The Journal of Immunology.

[40]  Simmie L. Foster,et al.  Gene-specific control of inflammation by TLR-induced chromatin modifications , 2007, Nature.

[41]  W. Cowden,et al.  IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. , 1996, Journal of immunology.

[42]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[43]  U. Vinkemeier,et al.  Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations , 2008, Proceedings of the National Academy of Sciences.

[44]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[45]  S. Szabo,et al.  Molecular mechanisms regulating Th1 immune responses. , 2003, Annual review of immunology.

[46]  L. Ivashkiv,et al.  IFN-γ and STAT1 Arrest Monocyte Migration and Modulate RAC/CDC42 Pathways1 , 2008, The Journal of Immunology.

[47]  S. Ghosh,et al.  Interfering with interferons in inflammatory bowel disease , 2005, Gut.

[48]  Xiaoyu Hu,et al.  Reprogramming of IL-10 Activity and Signaling by IFN-γ 1 , 2003, The Journal of Immunology.

[49]  M. Baccarini,et al.  IFN-gamma/lipopolysaccharide activation of macrophages is associated with protein kinase C-dependent down-modulation of the colony-stimulating factor-1 receptor. , 1992, Journal of immunology.

[50]  Kate Schroder,et al.  Signal integration between IFNgamma and TLR signalling pathways in macrophages. , 2006, Immunobiology.

[51]  Yulan Qing,et al.  Alternative Activation of STAT1 and STAT3 in Response to Interferon-γ* , 2004, Journal of Biological Chemistry.

[52]  D. Levy,et al.  Cooperation between STAT3 and c-jun suppresses Fas transcription. , 2001, Molecular cell.

[53]  James T. Elder,et al.  Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis1 , 2008, The Journal of Immunology.

[54]  J. Darnell,et al.  Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. , 2006, Genes & development.

[55]  R. Nakagawa,et al.  SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. , 2001, Immunity.

[56]  T. van der Poll,et al.  Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. , 1997, Journal of immunology.

[57]  B. Doble,et al.  Glycogen synthase kinase-3--an overview of an over-achieving protein kinase. , 2006, Current drug targets.

[58]  L. Hennighausen,et al.  Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system , 2006, Nature Immunology.

[59]  U. Schindler,et al.  Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[60]  K. Mikecz,et al.  IL-4 and IL-12 Regulate Proteoglycan-Induced Arthritis Through Stat-Dependent Mechanisms1 , 2002, The Journal of Immunology.

[61]  Pamela L. Schwartzberg,et al.  T Helper Cell Fate Specified by Kinase-Mediated Interaction of T-bet with GATA-3 , 2005, Science.

[62]  T. Wynn.  Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.

[63]  R. Baron,et al.  'Tuning' of type I interferon–induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages , 2008, Nature Immunology.

[64]  R. Stauber,et al.  Acetylation of Stat1 modulates NF-B activity , 2006 .

[65]  Paul J Hertzog,et al.  SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine , 1999, Cell.

[66]  Hiroshi Takayanagi,et al.  Interplay between interferon and other cytokine systems in bone metabolism , 2005, Immunological reviews.

[67]  Y. Fujii‐Kuriyama,et al.  Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells , 2008, Proceedings of the National Academy of Sciences.

[68]  Daniel J. Campbell,et al.  T-bet controls regulatory T cell homeostasis and function during type-1 inflammation , 2009, Nature Immunology.

[69]  D. Littman,et al.  Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.

[70]  M. David,et al.  Impaired Development of CD4+ CD25+ Regulatory T Cells in the Absence of STAT1 , 2004, The Journal of experimental medicine.

[71]  David E Levy,et al.  IFNgamma signaling-does it mean JAK-STAT? , 2008, Cytokine & growth factor reviews.

[72]  M. Gajda,et al.  Exacerbation of Antigen-Induced Arthritis in IFN-γ-Deficient Mice As a Result of Unrestricted IL-17 Response1 , 2007, The Journal of Immunology.

[73]  D. Hilton,et al.  Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. , 1999, Journal of immunology.

[74]  C. Hidaka,et al.  Homeostatic Role of Interferons Conferred by Inhibition of IL-1-Mediated Inflammation and Tissue Destruction , 2005, The Journal of Immunology.

[75]  H. Dickensheets,et al.  IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes. , 1997, Journal of immunology.

[76]  A. Yoshimura,et al.  Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads1 , 2008, The Journal of Immunology.

[77]  J. Darnell,et al.  Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[78]  C. Schindler,et al.  STATs Dimerize in the Absence of Phosphorylation* , 2003, Journal of Biological Chemistry.

[79]  L. Glimcher,et al.  Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13 , 2007, Proceedings of the National Academy of Sciences.

[80]  A. Ghosh,et al.  Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. , 2001, The Journal of biological chemistry.

[81]  D. Fremont,et al.  N-domain–dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation , 2004, Nature Immunology.

[82]  M. Dietrich,et al.  STAT3 inhibition of gluconeogenesis is downregulated by SirT1 , 2009, Nature Cell Biology.

[83]  W. Kaelin,et al.  The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. , 2005, Cancer cell.

[84]  Valeria Poli,et al.  Mutational switch of an IL-6 response to an interferon-γ-like response , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[85]  C. Uyttenhove,et al.  Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-γ and counteraction by interferon-γ , 2009, Arthritis research & therapy.

[86]  Jiahuai Han,et al.  Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. , 2008, Immunity.

[87]  J. Pedrosa,et al.  Cutting Edge: IFN-γ Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection1 , 2006, The Journal of Immunology.

[88]  A. Billiau,et al.  Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. , 1997, Journal of immunology.

[89]  W. B. van den Berg,et al.  Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. , 2001, Arthritis and rheumatism.

[90]  Xia Zhang,et al.  Interleukin‐10: new perspectives on an old cytokine , 2008, Immunological reviews.

[91]  A. Yoshimura,et al.  SOCS1 Deficiency Causes a Lymphocyte-Dependent Perinatal Lethality , 1999, Cell.

[92]  R. Young,et al.  Hematopoietic Remodeling in Interferon-γ–Deficient Mice Infected With Mycobacteria , 1998 .

[93]  L. Ivashkiv,et al.  IFN-γ-Primed Macrophages Exhibit Increased CCR2-Dependent Migration and Altered IFN-γ Responses Mediated by Stat11 , 2005, The Journal of Immunology.

[94]  Fiona Powrie,et al.  Hybrid Treg cells: steel frames and plastic exteriors , 2009, Nature Immunology.

[95]  A. Billiau,et al.  Protective role of IFN‐γ in collagen‐induced arthritis conferred by inhibition of mycobacteria‐induced granulocyte chemotactic protein‐2 production , 2007, Journal of leukocyte biology.

[96]  R. Schreiber,et al.  A Novel c-Jun-dependent Signal Transduction Pathway Necessary for the Transcriptional Activation of Interferon γ Response Genes* , 2007, Journal of Biological Chemistry.

[97]  A. Billiau,et al.  How interferon-gamma keeps autoimmune diseases in check. , 2008, Trends in immunology.

[98]  G. Stark,et al.  Cell Type-Specific Signaling in Response to Interferon-γ , 2007 .

[99]  M. Barrios-Rodiles,et al.  Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages. , 1998, Journal of immunology.

[100]  T. Taniguchi,et al.  Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. , 2000, Science.

[101]  M. McGeachy,et al.  Review Th17 Cell Differentiation: the Long and Winding Road , 2022 .

[102]  Margarida Saraiva,et al.  Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose , 2009, Immunity.

[103]  B. Ramratnam,et al.  Acetylation-Dependent Signal Transduction for Type I Interferon Receptor , 2007, Cell.

[104]  Masato Kubo,et al.  SOCS proteins, cytokine signalling and immune regulation , 2007, Nature Reviews Immunology.

[105]  S. Huang,et al.  High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. , 1997, Journal of immunology.

[106]  A. Rudensky,et al.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses , 2009, Nature.

[107]  T. van der Poll,et al.  Proinflammatory Effects of IL-10 During Human Endotoxemia1 , 2000, The Journal of Immunology.

[108]  Simmie L. Foster,et al.  Gene-specific control of the TLR-induced inflammatory response. , 2009, Clinical immunology.

[109]  J. Darnell,et al.  Structural bases of unphosphorylated STAT1 association and receptor binding. , 2005, Molecular cell.

[110]  E. So,et al.  IFN-γ and IFN-α Posttranscriptionally Down-Regulate the IL-4-Induced IL-4 Receptor Gene Expression1 , 2000, The Journal of Immunology.

[111]  Hiroshi Takayanagi,et al.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ , 2000, Nature.

[112]  B. Bauvois,et al.  Interferons Inhibit Tumor Necrosis Factor-α-mediated Matrix Metalloproteinase-9 Activation via Interferon Regulatory Factor-1 Binding Competition with NF-κB* , 2002, The Journal of Biological Chemistry.

[113]  A. Billiau,et al.  Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ , 2005, Arthritis research & therapy.

[114]  E. Benveniste,et al.  Transcriptional Suppression of Matrix Metalloproteinase-9 Gene Expression by IFN-γ and IFN-β: Critical Role of STAT-1α1 , 2001, The Journal of Immunology.

[115]  Kozo Nakamura,et al.  RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β , 2002, Nature.

[116]  K. Elkon,et al.  Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. , 2007, Arthritis and rheumatism.

[117]  Y. Yazaki,et al.  Induction of sustained expression of proto-oncogene c-fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblast growth factor, and its suppression by interferon-gamma and macrophage colony-stimulating factor in human aortic medial smooth muscle cells. , 1995, The Journal of clinical investigation.

[118]  J. O’Shea,et al.  Cytokine signaling modules in inflammatory responses. , 2008, Immunity.

[119]  R. Hirsch,et al.  EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.

[120]  L. Steinman.  A rush to judgment on Th17 , 2008, The Journal of experimental medicine.